Get the Stockscreener App
75.50
2.88%
2.11
After Hours:
74.22
-1.28
-1.70%
Globus Medical Inc stock is traded at $75.50, with a volume of 1.30M.
It is up +2.88% in the last 24 hours and down -6.00% over the past month.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
See More
Previous Close:
$73.39
Open:
$72.1
24h Volume:
1.30M
Relative Volume:
1.06
Market Cap:
$10.09B
Revenue:
$2.48B
Net Income/Loss:
$91.51M
P/E Ratio:
112.69
EPS:
0.67
Net Cash Flow:
$293.77M
1W Performance:
+1.55%
1M Performance:
-6.00%
6M Performance:
+7.89%
1Y Performance:
+45.70%
1-Day Range:
$71.73
$75.73
1-Week Range:
$70.67
$75.73
52-Week Range:
$49.33
$94.93
Globus Medical Inc Stock (GMED) Company Profile
Name
Globus Medical Inc
Sector
Industry
Phone
610-930-1800
Address
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA
Compare GMED with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GMED
Globus Medical Inc
|
75.50 | 10.09B | 2.48B | 91.51M | 293.77M | 0.67 |
|
ABT
Abbott Laboratories
|
131.93 | 228.81B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
100.05 | 149.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
377.46 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
88.86 | 113.49B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
72.05 | 42.10B | 5.72B | 4.17B | 259.90M | 6.97 |
Globus Medical Inc Stock (GMED) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-25 | Upgrade | BofA Securities | Underperform → Neutral |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-07-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| May-20-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Mar-18-24 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Sep-19-23 | Upgrade | Stifel | Hold → Buy |
| Mar-30-23 | Upgrade | Canaccord Genuity | Hold → Buy |
| Feb-13-23 | Downgrade | BofA Securities | Buy → Underperform |
| Feb-10-23 | Downgrade | BTIG Research | Buy → Neutral |
| Feb-10-23 | Downgrade | Loop Capital | Buy → Hold |
| Feb-10-23 | Downgrade | Needham | Buy → Hold |
| Feb-10-23 | Downgrade | Truist | Buy → Hold |
| Feb-10-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Apr-13-22 | Resumed | Truist | Buy |
| Mar-28-22 | Initiated | Wells Fargo | Overweight |
| Jan-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-13-21 | Upgrade | BofA Securities | Underperform → Buy |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Oct-29-21 | Initiated | Loop Capital | Buy |
| Feb-18-21 | Resumed | Needham | Buy |
| Dec-08-20 | Initiated | Citigroup | Buy |
| Oct-20-20 | Initiated | Stifel | Hold |
| Aug-06-20 | Reiterated | Needham | Buy |
| Aug-06-20 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jul-21-20 | Initiated | Northland Capital | Market Perform |
| Jul-06-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-08-20 | Reiterated | Needham | Buy |
| Mar-18-20 | Upgrade | BTIG Research | Neutral → Buy |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Dec-12-19 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Aug-02-19 | Reiterated | Needham | Buy |
| May-24-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
| May-03-19 | Reiterated | Needham | Buy |
| Feb-28-19 | Upgrade | UBS | Neutral → Buy |
| Jan-02-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Aug-02-18 | Reiterated | Needham | Buy |
| Jun-27-18 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jun-01-18 | Initiated | Cantor Fitzgerald | Overweight |
| May-03-18 | Reiterated | Needham | Buy |
| Apr-04-18 | Upgrade | Needham | Hold → Buy |
View All
Globus Medical Inc Stock (GMED) Latest News
Robotic-assisted Surgery Systems Market Set to Witness - openPR.com
Total Disc Replacement Market Future Business Opportunities - openPR.com
Levi & Korsinsky Reminds Shareholders of an Investigation into Globus Medical, Inc. (GMED) Regarding Potential Securities Fraud Allegations - ACCESS Newswire
Despite the downward trend in earnings at Globus Medical (NYSE:GMED) the stock grows 7.0%, bringing five-year gains to 80% - Yahoo Finance
Orthobiologics Market Future Business Opportunities - openPR
New Product Launches Benefit GMED Stock Amid Macro Issues - MSN
1 Healthcare Stock with Solid Fundamentals and 2 to Turn Down - Yahoo Finance
GMED Stock Jumps 41.8% in a Year: What's Behind the Rally? - Yahoo Finance
Globus Medical (NYSE:GMED) shareholders notch a 11% CAGR over 5 years, yet earnings have been shrinking - simplywall.st
Spinal Fusion Device Market Forecast Report and Company Analysis 2025-2033 Featuring Medtronic, Stryker, Zimmer Biomet, Orthofix Medical, NuVasive, Globus Medical, Xtant Medical, and Alphatec – Ortho Spine News - OrthoSpineNews
How Is The Market Feeling About Globus Medical? - Benzinga
Should You Hold Globus Medical Stock in Your Portfolio Now? - MSN
Spinal Fusion Device Market Forecast Report and Company - GlobeNewswire
Truist Financial Has Lowered Expectations for Globus Medical (NYSE:GMED) Stock Price - MarketBeat
Breaking Down Globus Medical: 5 Analysts Share Their Views - Benzinga
Stifel maintains Buy rating and $94 target on Globus Medical stock - Investing.com UK
Truist Cuts Price Target on Globus Medical to $82 From $90, Keeps Hold Rating -March 18, 2025 at 07:08 am EDT - MarketScreener
Interspinous Spacers Market Growth in Future Scope 2025-2032 | - openPR
Piper Sandler Sticks to Their Buy Rating for Globus Medical (GMED) - The Globe and Mail
Global Medical Handily Beats 2024 Sales Estimates - Orthopedics This Week
Globus Medical Expands Anterior Spine Portfolio With Two New Offerings - Yahoo Finance
Globus Medical Introduces Advanced Solutions for ALIF Surgery - MyChesCo
Globus Medical (NYSE:GMED) Stock Rating Upgraded by StockNews.com - Defense World
Globus Medical introduces new spine surgery solutions By Investing.com - Investing.com Canada
Globus Medical introduces new spine surgery solutions - Investing.com
Globus Medical Launches Innovative COHERE™ ALIF Spacer and Modulus™ ALIF Blades for Spine Surgery - Nasdaq
Globus Medical extends versatility of Advanced Materials Science™ anterior interbody portfolio - Bluefield Daily Telegraph
Globus Medical extends versatility of Advanced Materials - GlobeNewswire
Globus Medical extends versatility of Advanced Materials Science™ anterior interbody portfolio with launch of COHERE™ ALIF Spacer and Modulus™ ALIF Blades - Yahoo Finance
Hip Replacement Market Report and Company Analysis 2025-2033 Featuring Smith & Nephew, J&J, Integra, Zimmer Biomet, Stryker, B. Braun Melsungen, Globus Medical, MicroPort Scientific, Conformis - OrthoSpineNews
OsteoCentric Technologies Enters into a Non-Exclusive Licensing Agreement with Globus Medical - The Malaysian Reserve
Implantable Medical Devices Market growing at a CAGR of 7.2% from 2021 to 2030 | CONMED Corporation, Globus - EIN News
Hip Replacement Market Report and Company Analysis - GlobeNewswire
Medical Devices & SuppliesSpecialty Stocks Q4 In Review: Globus Medical (NYSE:GMED) Vs Peers - Yahoo Finance
Globus Medical to Showcase Cutting-Edge Innovations at 2025 AAOS Meeting - MSN
Proficio Capital Partners LLC Buys Shares of 14,392 Globus Medical, Inc. (NYSE:GMED) - Defense World
Globus Medical to feature ExcelsiusFlex™ for Total Knee - GlobeNewswire
Globus Medical to feature ExcelsiusFlex™ for Total Knee Arthroplasty at the American Academy of Orthopedic Surgeons Annual Meeting - The Manila Times
Globus Medical to Showcase Innovative Technologies at 2025 AAOS Annual Meeting in San Diego - Nasdaq
Globus Medical to feature ExcelsiusFlex™ for Total Knee Arthroplasty at the American Academy of ... - Bluefield Daily Telegraph
Globus Medical to feature ExcelsiusFlex™ for Total Knee Arthroplasty at the American Academy of Orthopedic - EIN News
Globus Medical to participate in the Canaccord Genuity 2025 Musculoskeletal Conference - GlobeNewswire
Can Globus Medical's Conference Presentation Reveal New Growth Strategy? - StockTitan
Is the Options Market Predicting a Spike in Globus Medical (GMED) Stock? - MSN
There May Be Reason For Hope In Globus Medical's (NYSE:GMED) Disappointing Earnings - Simply Wall St
Globus Medical's (NYSE:GMED) Soft Earnings Don't Show The Whole Picture - Yahoo Finance
Private Advisor Group LLC Boosts Stake in Globus Medical, Inc. (NYSE:GMED) - Defense World
Globus Medical Inc Stock (GMED) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.82%
1.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):